Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism

L Valcarcel-Jimenez, C Frezza - British Journal of Cancer, 2023 - nature.com
Fumarate hydratase (FH) is an enzyme of the Tricarboxylic Acid (TCA) cycle whose
mutations lead to hereditary and sporadic forms of cancer. Although more than twenty years …

Oncometabolites in renal cancer

C Yong, GD Stewart, C Frezza - Nature Reviews Nephrology, 2020 - nature.com
The study of cancer metabolism has evolved vastly beyond the remit of tumour proliferation
and survival with the identification of the role of 'oncometabolites' in tumorigenesis. Simply …

Fumarate hydratase in cancer: A multifaceted tumour suppressor

C Schmidt, M Sciacovelli, C Frezza - Seminars in cell & developmental …, 2020 - Elsevier
Cancer is now considered a multifactorial disorder with different aetiologies and outcomes.
Yet, all cancers share some common molecular features. Among these, the reprogramming …

ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/NF-κB pathway

Y Ji, C Ni, Y Shen, Z Xu, L Tang, F Yu, L Zhu, H Lu… - Molecular Cancer, 2024 - Springer
Background Emerging evidence indicates the pivotal involvement of circular RNAs
(circRNAs) in cancer initiation and progression. Understanding the functions and underlying …

Ponatinib and other CML tyrosine kinase inhibitors in thrombosis

P Zeng, A Schmaier - International Journal of Molecular Sciences, 2020 - mdpi.com
Abl1 kinase has important biological roles. The Bcr-Abl1 fusion protein creates undesired
kinase activity and is pathogenic in 95% of chronic myeloid leukemia (CML) and 30% of …

Important roles of protein tyrosine phosphatase PTPN12 in tumor progression

C Lee, I Rhee - Pharmacological Research, 2019 - Elsevier
Protein tyrosine phosphatases (PTPs), which are ubiquitously expressed in hematopoietic
and non-hematopoietic cells, are critical for regulating cell proliferation as well as …

Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies

RJ Salmond - Cells, 2024 - mdpi.com
Advances in immunotherapy have brought significant therapeutic benefits to many cancer
patients. Nonetheless, many cancer types are refractory to current immunotherapeutic …

The de-sulfinylation enzyme sulfiredoxin-1 attenuates hepatic stellate cell activation and liver fibrosis by modulating the PTPN12-NLRP3 axis

JW Kim, HC Tung, M Ke, P Xu, X Cai, Y Xi, M Xu… - Hepatology, 2024 - journals.lww.com
Hepatology Publish Ahead of Print DOI:10.1097/HEP.0000000000001133 Page 1 The de-sulfinylation
enzyme sulfiredoxin-1 attenuates hepatic stellate cell activation and liver fibrosis by …

Expression analysis of tyrosine phosphatase genes at different stages of renal cell carcinoma

I Laczmanska, L Laczmanski… - Anticancer Research, 2020 - ar.iiarjournals.org
Background: Renal cell carcinoma (RCC) is a common urological cancer, and its risk
correlates with environmental factors such as obesity, smoking and hypertension. Microarray …

Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma

Z Liang, X Li, F Duan, L Song, Z Wang, X Li, P Yang… - Human Cell, 2022 - Springer
Protein tyrosine phosphatase non-receptor type 12 (PTPN12) is abnormally expressed in
many human cancers. However, its role in hepatocellular carcinoma (HCC) is indeterminate …